Chronic diseases are the leading cause of death and disability. Common chronic diseases are ongoing, generally incurable illnesses or conditions.
Many serious chronic illnesses require frequent testing and monitoring to keep track of symptoms and vital signs for chronically ill patients, such as, blood pressure for cardiac patients, blood sugar levels for diabetes management.
Chronic disease management can be provided through convenient telehealth platform for patients who need ongoing medical attention. Telehealth allows providers to monitor and manage their patients’ chronic conditions in remote locations.
Telehealth is the use of digital technologies to deliver medical care and public health services by connecting multiple users in separate locations. Telehealth includes diagnosis and treatment of illness or injury, and services such as assessment, monitoring, communications, prevention and education.
As the advanced medical technology develops and the awareness of telehealth grows, chronic diseases management through telehealth becomes popular and convenient.
To cut down on patients’ travel costs and infection risk of COVID-19, along with other illness, the patients can be discharged with a remote monitoring device, such as Mintti-Vision, a multi-functional health monitor, which measures patients’ temperature, blood pressure, etc anytime and anywhere.
Mintti-Vision can be integrated with the clinician’s Electronic Medical Record (EMR) system for easy data analysis. It can help promote remote monitoring and communication between the patient and the physician with accurate data to provide seamless services for chronic patients and make treatment decisions and improve health outcomes.
Benefits of Telehealth with Mintti-Vision for the Patient with Chronic Conditions:
- Better preventative management for chronic conditions;
- Fewer visits to the emergency room;
- Reduced hospitalizations;
- Shorter hospital stays;
- Better health outcomes for patients in rural areas.
Benefits of Telehealth with Mintti-Vision for the Provider:
- Catching any complications faster;
- Improving clinical decision making;
- Triggering earlier clinical assessment and treatment;
- Helping modify drug therapy regimens;
- Helping patients improve self-management;
- Reinforcing patient adherence to medications;
- Optimizing clinical staff efficiency and combating clinical staff shortages.
Why Minttihealth
Minttihealth was the sole Chinese brand represented at the 2019 Sweden Vitalis and 2018 Germany ConhIt exhibitions, both of which are centered around telemedicine.
Minttihealth is one of merely two Chinese brands to have been included among the top 23 health wearable brands globally by AP.
Cardiology 2.0, a US-based media publication that covers innovations, breakthroughs, and trends in the cardiovascular realm, conducted an interview with Minttihealth as the exclusive Chinese brand in its coverage.
Minttihealth benefits from the contributions of a top-tier R&D team from the Chinese Academy of Sciences (CAS).
The exceptional marketing team at Minttihealth, whose members have been engaged as marketing trainers for Alibaba, is well-equipped to aid you in formulating your marketing strategy.
Minttihealth succeeded in developing the first FDA-approved electronic stethoscope from China.
The Mintti Smartho-D2, crafted by Minttihealth, was effectively employed in clinical settings at the Huoshenshan Hospital for diagnosing COVID-19 patients, receiving high praise.
CCTV Finance showcased Minttihealth’s electronic stethoscope as a pioneering achievement in China.
We look for partners rather than buyers.
For more information on Minttihealth, Mintti software, devices, and systems, or tailored solutions aligned with your business objectives and challenges, you can explore more on our website. To request a demo or contact us via email at info@minttihealth.com, we assure you of a prompt response to your inquiries.